OBJECTIVE: To develop and validate a tool for evaluating balance and neuromotor function in patients with fibromyalgia (FMS). METHODS: Brainstorming, the nominal group technique, and pilot-testing were used to select a battery of 20 functional balance tests that were included in a screening tool. A total of 108 subjects (62 with fibromyalgia syndrome, 22 aged over 65 years, and 24 healthy subjects) participated in this validation study. Factor validity, internal consistency, the ability to discriminate between patients and healthy subjects, and concurrent validity with the Fibromyalgia Impact Questionnaire (FIQ), the Central Sensitization Inventory (CSI), the 12-Item Short-Form Health Survey (SF-12), and other tools for measuring balance, such as the Dizziness Handicap Inventory (DHI), the Activities-Specific Balance Confidence Scale (ABC-16), the Falls Efficacy Scale-International (FES-I), and posturographic parameters, were evaluated. RESULTS: The factorial analysis extracted four factors that explained 70% of the variance. The Alpha Cronbach value was 0.928. Concurrent validity of the screening tool with respect to other tools was high, and the receiver operating characteristic (ROC) curve analysis showed an AUC value of 0.932 for discriminating between healthy and FMS subjects. Severe balance disorder related to head movements in FMS patients was found. CONCLUSION: The 20-item JAEN (Joint Assessment of Equilibrium and Neuro-motor Function) screening tool is a valid and reliable tool for assessing balance in patients with FMS.
OBJECTIVE: To develop and validate a tool for evaluating balance and neuromotor function in patients with fibromyalgia (FMS). METHODS: Brainstorming, the nominal group technique, and pilot-testing were used to select a battery of 20 functional balance tests that were included in a screening tool. A total of 108 subjects (62 with fibromyalgia syndrome, 22 aged over 65 years, and 24 healthy subjects) participated in this validation study. Factor validity, internal consistency, the ability to discriminate between patients and healthy subjects, and concurrent validity with the Fibromyalgia Impact Questionnaire (FIQ), the Central Sensitization Inventory (CSI), the 12-Item Short-Form Health Survey (SF-12), and other tools for measuring balance, such as the Dizziness Handicap Inventory (DHI), the Activities-Specific Balance Confidence Scale (ABC-16), the Falls Efficacy Scale-International (FES-I), and posturographic parameters, were evaluated. RESULTS: The factorial analysis extracted four factors that explained 70% of the variance. The Alpha Cronbach value was 0.928. Concurrent validity of the screening tool with respect to other tools was high, and the receiver operating characteristic (ROC) curve analysis showed an AUC value of 0.932 for discriminating between healthy and FMS subjects. Severe balance disorder related to head movements in FMS patients was found. CONCLUSION: The 20-item JAEN (Joint Assessment of Equilibrium and Neuro-motor Function) screening tool is a valid and reliable tool for assessing balance in patients with FMS.
Authors: W P A Kelders; G J Kleinrensink; J N van der Geest; L Feenstra; C I de Zeeuw; M A Frens Journal: J Physiol Date: 2003-08-29 Impact factor: 5.182
Authors: Kim D Jones; Fay B Horak; Kerri Winters-Stone; Jessica Morea Irvine; Robert M Bennett Journal: J Clin Rheumatol Date: 2009-02 Impact factor: 3.517
Authors: David Núñez-Fuentes; Esteban Obrero-Gaitán; Noelia Zagalaz-Anula; Alfonso Javier Ibáñez-Vera; Alexander Achalandabaso-Ochoa; María Del Carmen López-Ruiz; Daniel Rodríguez-Almagro; Rafael Lomas-Vega Journal: Diagnostics (Basel) Date: 2021-01-15
Authors: Mari Carmen Gomez-Alvaro; Santos Villafaina; Juan Luis Leon-Llamas; Alvaro Murillo-Garcia; María Melo-Alonso; Jesús Sánchez-Gómez; Pablo Molero; Ricardo Cano-Plasencia; Narcis Gusi Journal: Behav Sci (Basel) Date: 2022-02-04
Authors: Juan Luis Leon-Llamas; Alvaro Murillo-Garcia; Santos Villafaina; Francisco Javier Domínguez-Muñoz; Jesús Morenas; Narcis Gusi Journal: Int J Environ Res Public Health Date: 2022-07-06 Impact factor: 4.614